Socioeconomic factors affected resection type in NSCLC patients

October 2011
Hem/Onc Today;10/25/2011, Vol. 12 Issue 20, p30
The article discusses research study being done on the impact of socioeconomic and surgeon characteristics on non-small cell lung cancer patients undergoing lobectomy, referencing a study by S. E. Billmeier et al., published in a 2011 issue of "Journal of the National Cancer Institute."


Related Articles

  • The Impact of Adjustment for Socioeconomic Status on Comparisons of Cancer Incidence between Two European Countries. Donnelly, David W.; Hegarty, Avril; Sharp, Linda; Carsin, Anne-Elie; Deady, Sandra; McCluskey, Neil; Comber, Harry; Gavin, Anna // Journal of Cancer Epidemiology;2013, p1 

    Background. Cancer incidence rates vary considerably between countries and by socioeconomic status (SES). We investigate the impact of SES upon the relative cancer risk in two neighbouring countries. Methods. Data on 229,824 cases for 16 cancers diagnosed in 1995-2007 were extracted from the...

  • The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study. Forrest, L F; White, M; Rubin, G; Adams, J // British Journal of Cancer;7/29/2014, Vol. 111 Issue 3, p608 

    Background:Reducing socioeconomic inequalities in lung cancer treatment may reduce survival inequalities. However, the reasons for treatment variation are unclear.Methods:Northern and Yorkshire cancer registry, Hospital Episode Statistics and lung cancer audit data sets were linked. Logistic...

  • Combination Therapy May Hold Most Benefit for NSCLC Patients.  // RT: The Journal for Respiratory Care Practitioners;Feb2010, Vol. 23 Issue 2, p27 

    The article reports on the study which found that combination therapy provide most benefit for non-small cell lung cancer patients (NSCLC).

  • Lung Cancer Patients Smoke Themselves to Sleep.  // USA Today Magazine;Feb2011, Vol. 139 Issue 2789, p10 

    This article reports on a study on the prevalence of insomnia in patients with lung cancer.

  • In Numbers: Lung cancer.  // GP: General Practitioner;4/6/2015, p1 

    The article reports that the cancer charity Macmillan Cancer Support has stated that survival rates of lung cancer patients in Great Britain is lagging behind other European countries including Austria, Finland, Germany as of 2015.

  • Staging lung cancer.  // British Medical Journal;7/12/1980, Vol. 281 Issue 6233, p94 

    Focuses on the significance of staging in management of patients with lung cancer. Treatment of lung cancer; Information on the staging procedures; Importance of re-staging in small-cell cancer; Choice of systems of nomenclature for lung cancer.

  • Better access for the poor may improve lung cancer survival. Holzman, David // JNCI: Journal of the National Cancer Institute;Aug95, Vol. 87 Issue 16, p1212 

    Reports on the study on the influence of income on the survival of lung cancer patients in the United States. Access to treatment; Comparison of rates of surgery and long-term survival among income groups and race; Deficient insurance of Blacks and poor people; Refusal of blacks to undergo surgery.

  • Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years. Pasini, F; Verlato, G; Durante, E; de Manzoni, G; Valduga, F; Accordini, S; Pedrazzani, C; Terzi, A; Pelosi, G // British Journal of Cancer;6/2/2003, Vol. 88 Issue 11, p1666 

    Among patients with non-small-cell lung cancer (NSCLC), those with pathological stage I have the best expectation of survival; however, survival is reduced to less than 50% in the long term. At present, it is unclear when patients can be reasonably defined as cured, and if they experience a...

  • Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients. Nakashima, T; Huang, C; Liu, D; Kameyama, K; Masuya, D; Kobayashi, S; Kinoshita, M; Yokomise, H // British Journal of Cancer;6/2/2003, Vol. 88 Issue 11, p1727 

    An immunohistochemical analysis for E(epithelial)-cadherin and N(neural)-cadherin expression in relation to tumour angiogenesis was performed in 150 patients with non-small-cell lung cancer (NSCLC). In all, 71 carcinomas (47.3%) were E-cadherin-negative. Epithelial-cadherin-negative tumours had...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics